Invivyd Strengthens Leadership With Appointment Of Paul B. Bolno, M.D. To Board Of Directors

Invivyd, Inc. announced the appointment of Paul B. Bolno, M.D., to its Board of Directors, where he will also serve as a member of the Compensation Committee. Dr. Bolno is the President and Chief Executive Officer of Wave Life Sciences, a clinical-stage biotechnology company, a position he has held since 2013. Over the course of his career, he has gained extensive experience in applying technological platforms to develop innovative products and medicines. 

Alongside his leadership at Wave Life Sciences, he also serves on the Board of Directors of ExpressionEdits and holds the role of Chairman of the Scientific Advisory Group for the Nucleic Acid Therapy Accelerator. His background in advancing biotechnology through both strategic and scientific expertise is expected to bring valuable insights to Invivyd’s leadership team.

Marc Elia, Chairman of the Board of Invivyd, stated, “We are happy to have Dr. Bolno joined our Board at this critical moment while we transition toward a future focused on helping large populations avoid becoming ill from major viral infectious diseases. Dr. Bolno’s extensive experience in leading Wave Life Sciences through rapid pipeline development will be a boon to Invivyd as we seek to advance our pipeline so that we may help as many people as possible stay healthy from targeted infectious diseases.”

Paul B. Bolno, M.D., mentioned, “I am honored to join the Board of Invivyd, as we share a sense of urgency to keep Americans healthy via our deep commitment to scientific excellence. Invivyd’s unique capabilities and ability to drive meaningful innovation in viral infectious disease can add high quality options in prevention and treatment of acute COVID, and potentially treatment of Long COVID, all of which are sorely needed in modern American healthcare.”